Circulating gonadal and adrenal steroids in amyotrophic lateral sclerosis: Possible markers of susceptibility and outcome

Hormone and Metabolic Research

Volumn 46, Issue 6, 2014, Pages 433-439

  Gargiulo Monachelli, G M ^a,b   Sivori, M ^a   Meyer, M ^b   Sica, R E P ^a   De Nicola, A F ^a,b   Gonzalez Deniselle, M C ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

adrenal steroids; amyotrophic lateral sclerosis; gonadal steroids; hormones; motor neuron disease; respiratory function

Indexed keywords

CORTICOSTEROID; ESTRADIOL; HYDROCORTISONE; PRASTERONE; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE; TESTOSTERONE; BIOLOGICAL MARKER; STEROID;

ADULT; AGE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FORCED VITAL CAPACITY; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; LIMIT OF DETECTION; MALE; MAXIMAL EXPIRATORY PRESSURE; MAXIMAL INSPIRATORY PRESSURE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RESPIRATORY FUNCTION; RESPIRATORY TRACT PARAMETERS; STEROID BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; ADRENAL GLAND; BLOOD; BREATHING; CASE CONTROL STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; GONAD; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; VITAL CAPACITY;

ADRENAL GLANDS; AGE FACTORS; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; GONADS; HUMANS; MALE; MIDDLE AGED; RESPIRATION; STEROIDS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84901997004     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1371891     Document Type: Article

References (48)

1. Mitchell J. D., Borasio G. D. Amyotrophic lateral sclerosis. Lancet: 2007; 369 2031 2041
2. Haverkamp L. J., Appel V., Appel S. H. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain: 1995; 118 Pt 3 707 719
3. Baumann F., Henderson R. D., Morrison S. C., Brown M., Hutchinson N., Douglas J. A., Robinson P. J., McCombe P. A. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler: 2010; 11 194 202
4. Blasco H., Guennoc A. M., Veyrat-Durebex C., Gordon P. H., Andres C. R., Camu W., Corcia P. Amyotrophic lateral sclerosis: A hormonal condition? Amyotroph Lateral Scler: 2012; 13 585 588
5. Patacchioli F. R., Monnazzi P., Scontrini A., Tremante E., Caridi I., Brunetti E., Buttarelli F. R., Pontieri F. E. Adrenal dysregulation in amyotrophic lateral sclerosis. J Endocrinol Invest: 2003; 26 RC23 RC25 (Pubitemid 38324729)
6. Gargiulo M. G., Meyer M., Rodriguez G. E., Garay L. I., Sica R. E., De Nicola A. F., Gonzalez Deniselle M. C. Endogenous progesterone is associated to amyotrophic lateral sclerosis prognostic factors. Acta Neurol Scand: 2011; 123 60 67
7. Armanini D., Vecchio F., Basso A., Milone F. F., Simoncini M., Fiore C., Mattarello M. J., Sartorato P., Karbowiak I. Alzheimer's disease: pathophysiological implications of measurement of plasma cortisol, plasma dehydroepiandrosterone sulfate, and lymphocytic corticosteroid receptors. Endocrine: 2003; 22 113 118 (Pubitemid 38019117)
8. Blum C. A., Mueller C., Schuetz P., Fluri F., Trummler M., Mueller B., Katan M., Christ-Crain M. Prognostic value of dehydroepiandrosterone-sulfate and other parameters of adrenal function in acute ischemic stroke. PLoS One: 2013; 8 e63224
9. D'Astous M., Morissette M., Tanguay B., Callier S., Di Paolo T. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice. Synapse: 2003; 47 10 14 (Pubitemid 35424538)
10. Militello A., Vitello G., Lunetta C., Toscano A., Maiorana G., Piccoli T., La Bella V. The serum level of free testosterone is reduced in amyotrophic lateral sclerosis. J Neurol Sci: 2002; 195 67 70 (Pubitemid 34175101)
11. Vivekananda U., Manjalay Z. R., Ganesalingam J., Simms J., Shaw C. E., Leigh P. N., Turner M. R., Al Chalabi A. Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability. J Neurol Neurosurg Psychiatry: 2011; 82 635 637
12. Wicks P. Hypothesis: higher prenatal testosterone predisposes ALS patients to improved athletic performance and manual professions. Amyotroph Lateral Scler: 2012; 13 251 253
13. Groeneveld G. J., Van Muiswinkel F. L., Sturkenboom J. M., Wokke J. H., Bar P. R., Van den Berg L. H. Ovariectomy and 17beta-estradiol modulate disease progression of a mouse model of ALS. Brain Res: 2004; 1021 128 131 (Pubitemid 39158664)
14. Mitsumoto H., Ulug A. M., Pullman S. L., Gooch C. L., Chan S., Tang M. X., Mao X., Hays A. P., Floyd A. G., Battista V., Montes J., Hayes S., Dashnaw S., Kaufmann P., Gordon P. H., Hirsch J., Levin B., Rowland L. P., Shungu D. C. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology: 2007; 68 1402 1410 (Pubitemid 46659092)
15. Nagata T., Nagano I., Shiote M., Narai H., Murakami T., Hayashi T., Shoji M., Abe K. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients. Neurol Res: 2007; 29 772 776 (Pubitemid 350255149)
16. Ranganathan S., Nicholl G. C., Henry S., Lutka F., Sathanoori R., Lacomis D., Bowser R. Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects. Amyotroph Lateral Scler: 2007; 8 373 379 (Pubitemid 350176937)
17. Singh M., Su C. Progesterone-induced neuroprotection: Factors that may predict therapeutic efficacy. Brain Res: 2013; 1514 98 106
18. Schumacher M., Sitruk-Ware R., De Nicola A. F. Progesterone and progestins: neuroprotection and myelin repair. Curr Opin Pharmacol: 2008; 8 740 746
19. Behan M., Wenninger J. M. Sex steroidal hormones and respiratory control. Respir Physiol Neurobiol: 2008; 164 213 221
20. Joseph V., Behan M., Kinkead R. Sex, hormones, and stress: how they impact development and function of the carotid bodies and related reflexes. Respir Physiol Neurobiol: 2013; 185 75 86
21. Jackson C. E., Rosenfeld J., Moore D. H., Bryan W. W., Barohn R. J., Wrench M., Myers D., Heberlin L., King R., Smith J., Gelinas D., Miller R. G. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci: 2001; 191 75 78 (Pubitemid 33035898)
22. Tatsumi K., Pickett C. K., Jacoby C. R., Weil J. V., Moore L. G. Role of endogenous female hormones in hypoxic chemosensitivity. J Appl Physiol (1985): 1997; 83 1706 1710 (Pubitemid 27495353)
23. Gargiulo-Monachelli G., Campos Melo D., Droppelmann C., Keller B., Leystra Lantz Ch, De Nicola A. F., Gonzalez Deniselle M. C., Volkening K., Strong M. J. Expression and cellular localization of the classical progesterone receptor in healthy and amyotrophic lateral sclerosis affected spinal cord. Eur J Neurol: 2014; 21 273 280
24. Schumacher M., Mattern C., Ghoumari A., Oudinet J. P., Liere P., Labombarda F., Sitruk-Ware R., De Nicola A. F., Guennoun R. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog Neurobiol: 2014; 113 6 39
25. Brooks B. R., Miller R. G., Swash M., Munsat T. L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord: 2000; 1 293 299
26. Cedarbaum J. M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci: 1999; 169 13 21 (Pubitemid 29502501)
27. Nicolau G. Y., Lakatua D., Sackett-Lundeen L., Haus E. Circadian and circannual rhythms of hormonal variables in elderly men and women. Chronobiol Int: 1984; 1 301 319 (Pubitemid 15121451)
28. th ed. Philadelphia, Pa Saunders Elsevier: 2011
29. Vermeulen A., Verdonck L., Kaufman J. M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab: 1999; 84 3666 3672 (Pubitemid 30645223)
30. Maggio M., Colizzi E., Fisichella A., Valenti G., Ceresini G., Dall'Aglio E., Ruffini L., Lauretani F., Parrino L., Ceda G. P. Stress hormones, sleep deprivation and cognition in older adults. Maturitas: 2013; 76 22 44
31. Standardization of Spirometry, 1994 Update American Thoracic Society. Am J Respir Crit Care Med: 1995; 152 1107 1136
32. Black L. F., Hyatt R. E. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis: 1969; 99 696 702
33. McKim D. A., Katz S. L., Barrowman N., Ni A., LeBlanc C. Lung volume recruitment slows pulmonary function decline in Duchenne muscular dystrophy. Arch Phys Med Rehabil: 2012; 93 1117 1122
34. Ikeda K., Hirayama T., Takazawa T., Kawabe K., Iwasaki Y. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study. Intern Med: 2012; 51 1501 1508
35. R Development Core Team R: A Language and Environment for Statistical Computing. Vienna, Austria the R Foundation for Statistical Computing ISBN: 3-900051-07-0, 2011. Available online at http://www.R-project.org/
36. Mahendroo M. S., Mendelson C. R., Simpson E. R. Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem: 1993; 268 19463 19470 (Pubitemid 23270727)
37. Ishunina T. A., van Beurden D., van der M. G., Unmehopa U. A., Hol E. M., Huitinga I., Swaab D. F. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease. Neurobiol Aging: 2005; 26 173 194 (Pubitemid 39600577)
38. Ishunina T. A., Fischer D. F., Swaab D. F. Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol Aging: 2007; 28 1670 1681 (Pubitemid 47384954)
39. Costa J., Gomes C., de Carvalho M. Diagnosis, pathogenesis and therapeutic targets in amyotrophic lateral sclerosis. CNS Neurol Disord Drug Targets: 2010; 9 764 778
40. Markopoulou K., Papadopoulos A., Juruena M. F., Poon L., Pariante C. M., Cleare A. J. The ratio of cortisol/DHEA in treatment resistant depression. Psychoneuroendocrinology: 2009; 34 19 26
41. Ren J., Greer J. J. Neurosteroid modulation of respiratory rhythm in rats during the perinatal period. J Physiol: 2006; 574 535 546
42. Makino S., Fujiwara M., Handa H., Fujie T., Aoki Y., Hashimoto K., Terada Y., Sugimoto T. Plasma dehydroepiandrosterone sulphate and insulin-like growth factor I levels in obstructive sleep apnoea syndrome. Clin Endocrinol (Oxf): 2012; 76 593 601
43. Rasmuson S., Andrew R., Nasman B., Seckl J. R., Walker B. R., Olsson T. Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer's disease. Biol Psychiatry: 2001; 49 547 552 (Pubitemid 32226413)
44. González Deniselle M. C., Gonzalez S., Piroli G., Ferrini M., Lima A. E., De Nicola A. F. Glucocorticoid receptors and actions in the spinal cord of the Wobbler mouse, a model for neurodegenerative diseases. J Steroid Biochem Mol Biol: 1997; 60 205 213 (Pubitemid 27229775)
45. Fidler J. A., Treleaven C. M., Frakes A., Tamsett T. J., McCrate M., Cheng S. H., Shihabuddin L. S., Kaspar B. K., Dodge J. C. Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone. FASEB J: 2011; 25 4369 4377
46. Driver H. S., McLean H., Kumar D. V., Farr N., Day A. G., Fitzpatrick M. F. The influence of the menstrual cycle on upper airway resistance and breathing during sleep. Sleep: 2005; 28 449 456 (Pubitemid 40489839)
47. Slatkovska L., Jensen D., Davies G. A., Wolfe L. A. Phasic menstrual cycle effects on the control of breathing in healthy women. Respir Physiol Neurobiol: 2006; 154 379 388 (Pubitemid 44762240)
48. McCombe P. A., Henderson R. D. Effects of gender in amyotrophic lateral sclerosis. Gend Med: 2010; 7 557 570 Técnicas